The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases
Abstract
Summary: Depletion of B lymphocytes using the anti‐CD20 monoclonal antibody rituximab has wide‐spread use in the treatment of patients with autoimmune disorders. As haematopoietic progenitor cells and only a fraction of differentiated plasma express CD20, the effect of rituximab on immune function appears to be minimal. However, hypogammagobulinaemia can occur with repeated doses and emerging data from large studies suggest a subtle increase in the risk of infection. Reactivation of latent JC virus, resulting in progressive multifocal leucoencephalopathy, and hepatitis B virus, resulting in hepatoxicity, have been documented in patients receiving rituximab; although confounding effects of concomitant immunosuppressive therapies and immune dysregulation due to the underlying disease make causal associations of infections problematic. This review discusses the efficacy of B cell depletion therapy in the treatment of autoimmune diseases, the effect of B cell depletion on infection and immunity including the role of the B cell in autoimmunity, and identifies areas of controversy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
Self-citationAnti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754
Cited by
Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond
Karnell, J. L., Rieder, S. A., Ettinger, R., & Kolbeck, R. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.005 · Cited by 334
Casulo, C., Maragulia, J., & Zelenetz, A. D. (2013) · Clinical Lymphoma Myeloma and Leukemia · doi:10.1016/j.clml.2012.11.011 · Cited by 303
Roberts, M. B., & Fishman, J. A. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1189 · Cited by 277
Béland, K., Marceau, G., Labardy, A., Bourbonnais, S., & Alvarez, F. (2015) · Hepatology · doi:10.1002/hep.27991 · Cited by 93
Cytokine‐Producing B Cells Promote Immune‐Mediated Bile Duct Injury in Murine Biliary Atresia
Bednarek, J., Traxinger, B., Brigham, D., Roach, J., Orlicky, D., Wang, D., Pelanda, R., & Mack, C. L. (2018) · Hepatology · doi:10.1002/hep.30051 · Cited by 38
Metadata
- Authors
- Cooper, N., & Arnold, D. M.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2010-03-11
- Volume
- 149
- Issue
- 1
- Pages
- 3-13
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2093653074
- Cited by
- 159
- References
- 3
- FWCI
- 10.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases. https://app.cochat.ai/papers/10.1111/j.1365-2141.2010.08076.x
- The paper
- Cooper, N., & Arnold, D. M. (2010). The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.2010.08076.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.